- Home
- BSIN vs DXR Comparison
BSIN vs DXR Comparison
Compare BSIN & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
HOLD
Current Price
$8.60
Company Overview
Basic Information| Metric | BSIN | DXR |
|---|---|---|
| Founded | 1966 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 59.0M |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BSIN | DXR |
|---|---|---|
| Price | $1.35 | $8.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | $2.75 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 377.5K | 11.0K |
| Earning Date | 11-16-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,379,000.00 | $1,446,345.00 |
| Revenue This Year | $11.55 | $44,489.33 |
| Revenue Next Year | $169.70 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $8.40 |
| 52 Week High | $1.67 | $14.76 |
Technical Indicators
Market Signals| Indicator | BSIN | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 34.31 |
| Support Level | $1.37 | $8.56 |
| Resistance Level | $1.50 | $12.07 |
| Average True Range (ATR) | 0.07 | 0.38 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 21.74 | 27.26 |
Price Performance
Historical Comparison BSIN
DXR
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.